Quantitation of precipitating antibodies to certain soluble nuclear antigens in sle
β Scribed by Peter J. Maddison; Morris Reichlin
- Publisher
- John Wiley and Sons
- Year
- 1977
- Tongue
- English
- Weight
- 538 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Electrophoresis in polyacrylamide gels in the presence of sodium dodecyl sulfate was used to separate and quantitate the components of a washed immune precipitate. Serum was from patients with systemic lupus erythematosus known to have antibodies to soluble nuclear ribonucleoprotein (RNP) or to a soluble nuclear nonβnucleic acid protein (Sm). Amounts of antibody that was predominantly IgG ranged from 0.2 to 8 mg/ml of patients' serum, and in some cases accounted for over 20% of the total serum IgG. Results demonstrate that some patients respond to the disease by producing large amounts of a specific antibody, and that these antibodies can contribute significantly to hypergammaglobulinemia.
π SIMILAR VOLUMES
The clinical significance of antibodies to the Jo-1 antigen in connective tissue diseases was studied. Clinical diagnoses of 11 patients who had anti-Jo-1 antibody were: polymyositis 8, dermatomyositis 1, and overlap syndrome 2 (polymyositis--systemic lupus erythematosus 1, polymyositis--scleroderma
## Abstract The course of 81 patients with systemic lupus erythematosus (SLE) who had sera tested for antibody to extractable nuclear antigen (ENA) was studied to determine the effect of the presence of antiENA antibody on survivorship. There were no differences in percent survival between the pati
## Abstract Sera from infectious mononucleosis patients aged 2 to 35 years and from normal subjects aged 11 to 35 years were examined for the presence of antibody to the EB virus capsid antigen (VCA) in the indirect immunofluorescence test, and for the presence of antibody reactive with the soluble
The incidence of antibodies to Epstein-Barr nucleair antigen type 2 (EBNA-2) was determined in sera from rheumatoid arthritis (RA) patients and control subjects, by protein immunoblotting. Sixty-eight percent of the RA patients and 48% of the controls possessed anti-EBNA-2 antibodies. The titer of a